Sopharma AD (WSE:SPH)

Sopharma AD Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,012	2,101	2,022	1,294	1,304	940
Market Cap Growth	94.82%	3.91%	56.23%	-0.77%	38.76%	1.01%
Enterprise Value	5,368	2,971	2,923	2,011	2,084	1,867
Last Close Price	12.56	3.98	4.45	2.34	2.69	2.41
PE Ratio	14.82	12.31	9.48	7.61	6.21	13.50
PS Ratio	0.73	0.45	0.48	0.32	0.35	0.28
PB Ratio	1.87	1.13	1.21	0.76	0.84	0.71
P/TBV Ratio	2.65	1.70	1.34	0.83	0.96	0.84
P/FCF Ratio	-	22.15	44.09	5.96	-	-
P/OCF Ratio	99.53	12.51	20.21	4.92	-	-
EV/Sales Ratio	0.99	0.63	0.70	0.50	0.55	0.55
EV/EBITDA Ratio	10.45	12.00	10.29	7.07	9.47	10.78
EV/EBIT Ratio	15.21	17.76	14.10	9.79	14.45	18.45
EV/FCF Ratio	-102.69	31.32	63.73	9.27	-	-
Debt / Equity Ratio	0.65	0.56	0.47	0.40	0.50	0.75
Debt / EBITDA Ratio	3.24	3.59	2.41	2.10	2.95	4.84
Debt / FCF Ratio	-	11.10	17.00	3.12	-	-
Asset Turnover	1.40	1.29	1.37	1.36	1.32	1.20
Inventory Turnover	4.34	4.24	4.76	4.89	4.65	4.37
Quick Ratio	0.67	0.52	0.70	0.66	0.70	0.56
Current Ratio	1.31	1.17	1.29	1.41	1.35	1.12
Return on Equity (ROE)	14.42%	10.28%	13.59%	11.10%	14.97%	4.43%
Return on Assets (ROA)	4.20%	2.88%	4.21%	4.37%	3.14%	2.24%
Return on Invested Capital (ROIC)	6.88%	6.06%	8.57%	7.98%	6.02%	3.61%
Return on Capital Employed (ROCE)	9.80%	7.10%	10.30%	10.10%	7.90%	6.20%
Earnings Yield	6.75%	8.13%	10.55%	13.14%	16.09%	7.41%
FCF Yield	-1.30%	4.52%	2.27%	16.77%	-17.32%	-50.43%
Dividend Yield	2.85%	2.85%	16.47%	20.48%	-	-
Payout Ratio	20.91%	216.37%	74.90%	0.01%	0.07%	75.97%
Buyback Yield / Dilution	46.99%	-19.22%	-10.64%	0.36%	0.31%	0.11%
Total Shareholder Return	49.84%	-16.36%	5.83%	20.85%	0.31%	0.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.